Concepedia

Hwan-Soo Jae

HJ

Statistics

Publications

14

Citations

643

H-Index

13

Active since

1994

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Hwan-Soo Jae is an author at Abbott Fund specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1994–2006

14

Publications

14

2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ET<sub>A</sub> Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722

Martin Winn, Thomas W von Geldern, Terry J. Opgenorth et al. · Journal of Medicinal Chemistry · 1996 · 113 citations · Full text

, , +17

Liver-Selective Glucocorticoid Antagonists:  A Novel Treatment for Type 2 Diabetes

Thomas W von Geldern, Noah P. Tu, Philip R. Kym et al. · Journal of Medicinal Chemistry · 2004 · 71 citations · Full text

, , +17

A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.

Sajid Khan Tahir, Edward K. Han, B Credo et al. · PubMed · 2001 · 66 citations

, , +16

New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models

Bruce G. Szczepankiewicz, Gang Liu, Hwan-Soo Jae et al. · Journal of Medicinal Chemistry · 2001 · 66 citations

, , +16

Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: <i>ex vivo</i> and <i>in vivo</i> studies

Jerry L. Wessale, Andrew Adler, Eugene I. Novosad et al. · Clinical Science · 2002 · 61 citations

, , +10

1–5 of 14